Invention Grant
- Patent Title: Insulin infusion device with configurable target blood glucose value for automatic basal insulin delivery operation
-
Application No.: US16419401Application Date: 2019-05-22
-
Publication No.: US11097052B2Publication Date: 2021-08-24
- Inventor: Louis J. Lintereur , Benyamin Grosman , Anirban Roy , Neha J. Parikh , Di Wu
- Applicant: MEDTRONIC MINIMED, INC.
- Applicant Address: US CA Northridge
- Assignee: MEDTRONIC MINIMED, INC.
- Current Assignee: MEDTRONIC MINIMED, INC.
- Current Assignee Address: US CA Northridge
- Agency: Shumaker & Sieffert, P.A.
- Main IPC: A61M5/172
- IPC: A61M5/172

Abstract:
An insulin infusion device and related operating methods are disclosed. An operating method maintains a configurable, patient-specific, target glucose setpoint for a user of the insulin infusion device, collects historical data associated with operation of the insulin infusion device, and calculates, from the historical data, a target glucose setpoint profile for the user of the insulin infusion device. A current target glucose setpoint value is automatically adjusted over time during a closed-loop operating mode of the insulin infusion device, in accordance with the calculated target glucose setpoint profile. In certain embodiments, the historical data is analyzed to determine a clinically preferred target glucose setpoint value for the user, which is stored for use during the closed-loop operating mode.
Information query
IPC分类: